Who Just Raised
Get Pro

Mansfield, MA · Health Care · Form D filed Oct 8, 2026No press found

Bioventrix, Inc. raised $1.2M

Bioventrix, Inc. is a biotechnology company based in Mansfield, Massachusetts. In a Form D filed with the SEC on October 8, 2026, it reported raising $1,200,000 from 6 investors as part of an offering of up to $3,000,000. The first sale in the offering took place on September 29, 2026.

OUR VISION: Extend Life Span and Improve Quality of Life for Heart Failure Patients OUR VISION Extending Life Span and Improving Quality of Life for Heart Failure Patients How Revivent Therapy May…

No press found. No news article or press release about this raise turned up when we searched on October 17, 2026. Announcements sometimes come weeks after a filing, so we check again. More raises with no press found

$91M raised since 2020

10 Form D offerings, as reported to the SEC, the first in Jan 6, 2020. Amendments update a round; they aren't counted twice.

FiledSoldOffering sizeInvestors
Oct 8, 2026$1.2M$3M6
Apr 24, 2026$3M$10M25
Oct 15, 2024$6.7M$12M45
Mar 29, 2024$3M$3M21
Apr 4, 2023$12.7M$15.7M12
Jan 25, 2023$2M$3M18
Apr 6, 2022$1M$10M1
Jan 11, 2022$6M$6M5

and 2 earlier.

Placement agents: Finalis Securities LLC, The Benchmark Company, LLC, Third500, LLC, Taglich Brothers, Inc.

Lead score

44 out of 100

filed recently still raising budget to spend no press yet website found

Outreach kit How it works 1:21

A first message that shows you did your homework, written from this filing. Fill in the brackets and send.

Email · subject: Congrats on the new round

Hi [first name],

Congrats on the new round. I saw the raise in your SEC filing.

Teams at this stage usually start looking at [what you do] right after a round...

[Your name]

LinkedIn note

Congrats on the new round. I work with [who you help] on [what you do] right after a raise. Open to connecting?

Call opener

Hi, this is [your name] from [company]. I am calling because you just filed a raise with the SEC...

Find the right person Founders & CEO · Finance · Operations · People & hiring · Sales & marketing

Track this company How it works 0:56

Saved to your dashboard pipeline, with a badge in Explore.

Loading your outreach kit…

The outreach kit is part of Pro. Copy-ready email, LinkedIn and call openers for every new raise, plus daily alerts for the companies you sell to.

Start your free trial Already on Pro? Sign in

Filing details

Website
bioventrix.com
Amount raised
$1,200,000
Offering size
$3,000,000
Investors so far
6
Minimum investment
$50,000
First sale
September 29, 2026
Securities offered
Debt, Options or warrants, Securities issuable on exercise or conversion
Exemption claimed
Rule 506(b)
Industry
Biotechnology
Headquarters
Mansfield, Massachusetts
Incorporated
Delaware
Entity type
Corporation

Filings

FiledFormRaisedOffering sizeInvestorsSource
D (new notice) $1,200,000 $3,000,000 6 SEC filing
D/A (amendment) $2,965,000 $10,000,000 25 SEC filing
D/A (amendment) $2,765,000 $10,000,000 9 SEC filing

Figures come from the company's own filings with the SEC and are shown as reported. How to read a Form D.

Updated · Raises in the week of Oct 5, 2026 · Health Care funding in Massachusetts

Health Care $2.6M

Axelyf, Inc.

Chestnut Hill, MA · filed Oct 13

2nd Form D since 2025

Health Care $850K

Soterya, Inc.

Boston, MA · filed Oct 13

First Form DStill raising

Health Care $15M

Revbio, Inc.

Lowell, MA · filed Oct 2

TETRANITE is a regenerative bone glue. Bioengineered for a body of applications, TETRANITE® promises to transform bone repair.

4th Form D since 2019

Health Care $681K

Opus KSD, Inc.

Pembroke, MA · filed Oct 1

3rd Form D since 2016

Health Care $10M

Xact Bio, Inc.

Boston, MA · filed Sep 28

First Form DStill raising

Health Care $1.5M

AutoIVF, Inc.

Natick, MA · filed Sep 25

4th Form D since 2020

Who Just Raised Pro

The raises that matter to you, in your inbox every weekday morning.

Your sectors, states and deal size · first-time vs repeat raisers · open rounds · a watchlist · every raise as a spreadsheet each Monday.